Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility
Heart failure is characterized by depressed contractility and delayed repolarization. The latter feature predisposes the failing heart to ventricular arrhythmias and represents a logical target for gene therapy. Unfortunately, unopposed correction of the delay in repolarization will decrease the tim...
Guardado en:
| Autores principales: | Ennis, Irene Lucía, Li, Ronald A., Murphy, Anne M., Marbán, Eduardo, Nuss, H. Bradley |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2002
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/84675 |
| Aporte de: |
Ejemplares similares
-
Frequency-dependent changes in calcium cycling and contractile activation in SERCA2a transgenic mice
por: Hashimoto, Katsuji, et al.
Publicado: (2000) -
Phospholamban: a tiny protein with a prominent role in the regulation of cardiac relaxation and contractility
por: Mattiazzi, Alicia Ramona, et al.
Publicado: (2010) -
Dual effects of low and high dose caffeine
por: Gan, Siew H., et al.
Publicado: (2009) -
β₂-Adrenergic stimulation is involved in the contractile dysfunction of the stunned heart
por: Vittone, Leticia Beatriz, et al.
Publicado: (2006) -
Cardiac contractility structure-activity relationship and ligand-receptor interactions; the discovery of unique and novel molecular switches in myosuppressin signaling
por: Leander, Megan, et al.
Publicado: (2015)